Fat Burners

Sibutramine 20 mg Astera Labs

Astera Labs

85,00

In Stock (100 available)

Sibutramine 20 mg Astera Labs (20 mg) — Manufactured by Astera Labs to exacting pharmaceutical standards, sibutramine is a serotonin-norepinephrine reuptake inhibitor use…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost
Categories: ,

Description

Sibutramine 20 mg Astera Labs — Manufactured to exacting pharmaceutical standards, sibutramine is a serotonin-norepinephrine reuptake inhibitor used as an appetite suppressant for weight management. It reduces hunger signals and increases satiety, supporting significant fat loss during cutting phases. This formulation is dosed at 20 mg per unit.

Key Benefits

  • Serotonin-norepinephrine reuptake inhibitor — centrally-acting appetite suppressor
  • Metabolic rate elevation modest; mechanism primarily satiety
  • Withdrawn from many markets due to cardiovascular signal
  • Oral daily dosing during cutting
  • Not first-line in modern weight-loss protocols (GLP-1 agonists preferred)
  • Each unit dosed at 20 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Clinical dosing (historical): 10–15 mg/day, single morning dose. Cycles 8–12 weeks with careful BP and heart-rate monitoring. Modern protocols largely replace sibutramine with GLP-1 agonists.

How It Works

Central serotonin and norepinephrine reuptake inhibitor (SNRI). Increases satiety signals and modestly raises basal metabolic rate. Withdrawn from EU, US, and most developed markets in 2010 after cardiovascular-event signal in SCOUT trial.

Pharmacokinetics

Plasma half-life approximately 14–16 hours (active metabolites longer). Daily morning dosing. Steady-state 4–5 days.

Potential Side Effects

Blood-pressure elevation, tachycardia, dry mouth, insomnia. Cardiovascular events in susceptible individuals — primary reason for market withdrawal. Not for hypertensive or CVD patients.

Cycle & Stacking Guide

8–12 week cutting protocols with weekly BP monitoring. Modern alternative: semaglutide or tirzepatide with far cleaner safety profile.

Manufacturer Notes

Astera Labs produces a broad catalogue from research peptides to AAS oils. Lyophilised peptide vials ship with stability documentation.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Sibutramine 20 mg Astera Labs”

Your email address will not be published. Required fields are marked *